Class II · Moderate risk
All cetirizine Products
Lack of Processing Controls
FDA drug recalls in 2016
Every FDA drug recall initiated in 2016, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,199 recalls, newest first.
Class II · Moderate risk
All arginine Products
Lack of Processing Controls
Class II · Moderate risk
All T4-levothyroxine Products
Lack of Processing Controls
Class II · Moderate risk
All thymol Products
Lack of Processing Controls
Class II · Moderate risk
All PCCA Lipoderm Products
Lack of Processing Controls
Class II · Moderate risk
All tetracaine Products
Lack of Processing Controls
Class II · Moderate risk
All propylparaben Products
Lack of Processing Controls
Class II · Moderate risk
All methimazole Products
Lack of Processing Controls
Class II · Moderate risk
All fluocinonide Products
Lack of Processing Controls
Class II · Moderate risk
All Germall
Lack of Processing Controls
Class II · Moderate risk
All betamethasone diproprionate Products
Lack of Processing Controls
Class II · Moderate risk
All monobenzone Products
Lack of Processing Controls
Class II · Moderate risk
All carbomer Products
Lack of Processing Controls
Class II · Moderate risk
All progesterone Products
Lack of Processing Controls
Class II · Moderate risk
All Peterson Cream Products
Lack of Processing Controls
Class II · Moderate risk
All TRIE Products
Lack of Processing Controls
Class II · Moderate risk
All estriol Products
Lack of Processing Controls
Class II · Moderate risk
All testosterone Products
Lack of Processing Controls
Class I · High risk
Cap-Biotin 100 Mg
Labeling: Label Mix-Up: Products labeled Biotin 100 mg found to contain 4-aminopyridine
Class II · Moderate risk
All 4-aminopyridine Products
Lack of Processing Controls
Class III · Low risk
Venlafaxine 75 mg Tablet
Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.
Class I · High risk
5% Dextrose Injection USP
Non-Sterility: fungal contamination due to leaking containers.
Class III · Low risk
Escitalopram Tablets USP 20 mg
Labeling: Incorrect or Missing Lot and/or Expiration Date
Class III · Low risk
Zemplar (paricalcitol)
Failed Content Uniformity Specifications
Class III · Low risk
Simvastatin Tablets
Subpotent Drug